This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2008 Feb;135(2):148-53; quiz 147, 154.

doi: 10.1016/j.annder.2007.12.006. Epub 2008 Feb 13.

[Cutaneous side effects of sorafenib and sunitinib]

[Article in French]

J Autier¹, C Mateus, J Wechsler, A Spatz, C Robert

Affiliations

PMID: 18342102
DOI: 10.1016/j.annder.2007.12.006

Review

[Cutaneous side effects of sorafenib and sunitinib]

[Article in French]

J Autier et al. Ann Dermatol Venereol. 2008 Feb.

. 2008 Feb;135(2):148-53; quiz 147, 154.

doi: 10.1016/j.annder.2007.12.006. Epub 2008 Feb 13.

Authors

J Autier¹, C Mateus, J Wechsler, A Spatz, C Robert

Affiliation

¹ Service de dermatologie, institut Gustave-Roussy, 39, rue Camille-Desmoulins, 94805 Villejuif cedex, France.

PMID: 18342102
DOI: 10.1016/j.annder.2007.12.006

No abstract available

PubMed Disclaimer

Similar articles

A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib.
Patel TV, Morgan JA, Demetri GD, George S, Maki RG, Quigley M, Humphreys BD. Patel TV, et al. J Natl Cancer Inst. 2008 Feb 20;100(4):282-4. doi: 10.1093/jnci/djm311. Epub 2008 Feb 12. J Natl Cancer Inst. 2008. PMID: 18270341 No abstract available.
Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
Lee WJ, Lee JL, Chang SE, Lee MW, Kang YK, Choi JH, Moon KC, Koh JK. Lee WJ, et al. Br J Dermatol. 2009 Nov;161(5):1045-51. doi: 10.1111/j.1365-2133.2009.09290.x. Epub 2009 May 5. Br J Dermatol. 2009. PMID: 19558553
[Cutaneous side effects of the multikinase inhibitors sorafenib and sunitinib].
Wollenberg A, Staehler M, Eames T. Wollenberg A, et al. Hautarzt. 2010 Aug;61(8):662-7. doi: 10.1007/s00105-010-1942-7. Hautarzt. 2010. PMID: 20631979 Review. German.
Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib.
McLellan B, Kerr H. McLellan B, et al. Dermatol Ther. 2011 Jul-Aug;24(4):396-400. doi: 10.1111/j.1529-8019.2011.01435.x. Dermatol Ther. 2011. PMID: 21910797 Review.
Risk of arterial thrombosis not increased by sorafenib or sunitinib.
Minor DR. Minor DR. J Clin Oncol. 2010 Oct 20;28(30):e619; author reply e620. doi: 10.1200/JCO.2010.31.0219. Epub 2010 Aug 23. J Clin Oncol. 2010. PMID: 20733133 No abstract available.

See all similar articles

Cited by

Sorafenib-associated facial acneiform eruption.
Cohen PR. Cohen PR. Dermatol Ther (Heidelb). 2015 Mar;5(1):77-86. doi: 10.1007/s13555-014-0067-9. Epub 2014 Dec 25. Dermatol Ther (Heidelb). 2015. PMID: 25539704 Free PMC article.
Cutaneous side effects associated with sunitinib: an analysis of 8 cases.
Vignand-Courtin C, Martin C, Le Beller C, Mateus C, Barbault-Foucher S, Rieutord A. Vignand-Courtin C, et al. Int J Clin Pharm. 2012 Apr;34(2):286-9. doi: 10.1007/s11096-012-9615-5. Epub 2012 Mar 17. Int J Clin Pharm. 2012. PMID: 22427001
Multikinase inhibitor-associated hand-foot skin reaction as a predictor of outcomes in patients with hepatocellular carcinoma treated with sorafenib.
Ochi M, Kamoshida T, Ohkawara A, Ohkawara H, Kakinoki N, Hirai S, Yanaka A. Ochi M, et al. World J Gastroenterol. 2018 Jul 28;24(28):3155-3162. doi: 10.3748/wjg.v24.i28.3155. World J Gastroenterol. 2018. PMID: 30065561 Free PMC article.
The effect of the RadioProtect cosmetic formulation on the skin of oncological patients treated with selected cytostatic drugs and ionizing radiation.
Igielska-Kalwat J, Połoczańska-Godek S, Murawa D, Poźniak-Balicka R, Wachowiak M, Demski G, Cieśla S. Igielska-Kalwat J, et al. Postepy Dermatol Alergol. 2022 Feb;39(1):47-51. doi: 10.5114/ada.2022.113608. Epub 2022 Feb 28. Postepy Dermatol Alergol. 2022. PMID: 35369633 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Masson (France)